Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines

Gene mutations in PIK3CA, PIK3R1, KRAS, PTEN, and PPP2R1A commonly detected in type I endometrial cancer lead to PI3K/Akt/mTOR pathway activation. Bimiralisib (PQR309), an orally bioavailable selective dual inhibitor of PI3K and mTOR, has been studied in preclinical models and clinical trials. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsin, I-Lun, Shen, Huang-Pin, Chang, Hui-Yi, Ko, Jiunn-Liang, Wang, Po-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616154/
https://www.ncbi.nlm.nih.gov/pubmed/34831139
http://dx.doi.org/10.3390/cells10112916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616154/
https://www.ncbi.nlm.nih.gov/pubmed/34831139
http://dx.doi.org/10.3390/cells10112916

Ejemplares similares